—Mkt Cap: —P/E: —
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operate…
Industry Peers
Health Care Technologyloading…
Indicators:|
Key Statistics
Company
Market Cap—
Enterprise Value2.95B USD
Revenue (TTM)1.64B USD
Gross Profit831.62M USD
Net Income (TTM)-516.47M USD
Revenue/Share21.41 USD
Last Price—
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees4.4K
CountryUS
SectorHealth Care
IndustryHealth Care Technology
ISINUS4579852082
Valuation
P/E (Trailing)—
P/E (Forward)5.79
PEG0.67
EV/EBITDA9.57
EV/Revenue1.79
P/S0.72
P/B1.13
EPS (TTM)-6.47
EPS (Forward)2.61
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin50.86%
Oper. Margin10.41%
EBITDA Margin18.75%
Profit Margin-31.58%
ROE-49.50%
ROA-14.34%
Growth
Revenue Growth2.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF50.38M USD
CapEx (TTM)95.64M USD
FCF Margin4.21%
FCF Yield—
Net Debt1.78B USD
Net Debt/EBITDA5.76
Balance Sheet
Debt/Equity1.95
Current Ratio3.38
Quick Ratio1.53
Book Value/Sh13.40 USD
Cash/Share3.413 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split2:1
Split DateJan 4, 2017
Analyst Consensus
Rating3.1 (Hold)
Target (Mean)16.71 USD
Target Range11.00 USD – 27.00 USD
# Analysts7
Ownership
Shares Out.77.80M
Float58.69M
Insiders14.41%
Institutions100.52%
Short Interest
Short Ratio13.0d
Short % Float16.53%
Short % Out.11.99%
Shares Short9.33M
Short (prev mo.)8.86M
Technical
SMA 5011.04 USD
SMA 20012.53 USD
Beta1.08
S&P 52W Chg28.31%
Avg Vol (30d)—
Avg Vol (10d)1.11M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—